Cite
An investigator-blind randomized controlled trial comparing effectiveness, safety of levocetirizine and bepotastine in chronic urticaria.
MLA
Sil, Amrita, et al. “An Investigator-Blind Randomized Controlled Trial Comparing Effectiveness, Safety of Levocetirizine and Bepotastine in Chronic Urticaria.” Indian Journal of Dermatology, vol. 66, no. 5, Sept. 2021, pp. 472–78. EBSCOhost, https://doi.org/10.4103/ijd.ijd_813_20.
APA
Sil, A., Rahaman, S., Mondal, N., Ahmed, S., Tarafdar, D., Patra, A., Roy, S., & Das, N. (2021). An investigator-blind randomized controlled trial comparing effectiveness, safety of levocetirizine and bepotastine in chronic urticaria. Indian Journal of Dermatology, 66(5), 472–478. https://doi.org/10.4103/ijd.ijd_813_20
Chicago
Sil, Amrita, Sufiur Rahaman, Nasiruddin Mondal, Sk Ahmed, Dhiman Tarafdar, Aparesh Patra, Sudipta Roy, and Nilay Das. 2021. “An Investigator-Blind Randomized Controlled Trial Comparing Effectiveness, Safety of Levocetirizine and Bepotastine in Chronic Urticaria.” Indian Journal of Dermatology 66 (5): 472–78. doi:10.4103/ijd.ijd_813_20.